Essential fatty acids and psychiatric disorders

Nutrition in Clinical Practice

Volumn 26, Issue 4, 2011, Pages 409-425

  Perica, Marina Mandelsamen ^a   Delaš, Ivančica ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

bipolar disorder; depression; fatty acids, essential; lipids; schizophrenia; stress disorders, posttraumatic

Indexed keywords

ADRENIC ACID; ARACHIDONIC ACID; CERAMIDE; CEREBROSIDE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; ICOSATETRAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LITHIUM CARBONATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MOOD STABILIZER; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; SEROTONIN UPTAKE INHIBITOR; SPHINGOMYELIN; STEARIDONIC ACID; SULFATIDE; TRIACYLGLYCEROL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ANXIETY; BIPOLAR DISORDER; BRAIN DEVELOPMENT; BRAIN FUNCTION; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; LIPID BRAIN LEVEL; LIPID COMPOSITION; MAJOR DEPRESSION; MENTAL STRESS; MOOD DISORDER; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOTHERAPY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

BRAIN; DIETARY FATS; DIETARY SUPPLEMENTS; FATTY ACIDS, ESSENTIAL; HUMANS; LIPID METABOLISM; MENTAL DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 79960685747     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533611411306     Document Type: Review

References (117)

1. Owen C, Rees AM, Parker G. The role of fatty acids in the development and treatment of mood disorders. Curr Opin Psychiatry. 2008 ; 21 (1). 19-24 (Pubitemid 351339803)
2. Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry. 2000 ; 12: 159-165
3. Pauwels EKJ, Volterrani D. Fatty acid facts, part I: essential fatty acids as treatment for depression, or food for mood?. Drug News Perspect. 2008 ; 21 (8). 446-451
4. Haag M. Essential fatty acids and the brain. Can J Psychiatry. 2003 ; 48 (3). 195-203 (Pubitemid 36603376)
5. Lattka E, Illig T, Heinrich J, Koletzko B. Do FADS genotypes enhance our knowledge about fatty acid related phenotypes?. Clin Nutr. 2010 ; 29: 277-287
6. Trivedi B. The good, the fad, and unhealthy. New Scientist. 2006 ; 191 (2570). 42-49
7. Moore SA, Yoder E, Spector AA. Role of the blood-brain barrier in the formation of long-chain omega-3 and omega-6 fatty acids from essential fatty acid precursors. J Neurochem. 1990 ; 55 (2). 391-402
8. Schaefers HJ, Haselmann J, Goppelt-Struebe M. Regulation of prostaglandin synthesis in Madin Darby canine kidney cells: role of prostaglandin G/H synthase and secreted phospholipase A2. Biochim Biophys Acta. 1996 ; 1300 (3). 197-202 (Pubitemid 26195820)
9. Calder PC. Immunomodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Proc Nutr Soc. 1996 ; 55 (2). 737-774 (Pubitemid 126768953)
10. O'Brien JS, Sampson EL. Lipid composition of normal human brain: gray matter, white matter, and myelin. J Lipid Res. 1965 ; 6: 537-544
11. O'Brien JS, Sampson EL. Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J Lipid Res. 1965 ; 6: 537-544
12. Salem N, Kim H-Y, Yergey JA Health Effects of Polyunsaturated Fatty Acids in Seafoods. Simopoulos AP Kiter RR Martin RE, ed. New York: Academic Press ; 1986: 263-317.
13. Ikemoto A, Kobayashi T, Watanabe S, Okuyama H. Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release. Neurochem Res. 1997 ; 22 (6). 671-678 (Pubitemid 27242241)
14. Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during aging. J Nutr Health Aging. 2004 ; 8: 163-174 (Pubitemid 38678591)
15. Cook HW. In vitro formation of polyunsaturated fatty acids by desaturation in rat brain: some properties of the enzyme in developing brain and comparison with liver. J Neurochem. 1978 ; 30: 1327-1324
16. Purvis M, Clandinin MT, Hacker RR. Chain elongation-desaturation of linoleic acid during the development of the pig: implications for the supply of polyenoic fatty acids to the developing brain. Comp Biochem Physiol. 1983 ; 75B: 199-204 (Pubitemid 13039457)
17. Delaš I, PopoviA M, PetroviA T, Delaš F, IvankoviA D. Changes in the fatty acid composition of brain and liver phospholipids from rats fed fat-free diet. Food Technol Biotechnol. 2008 ; 3: 278-285
18. Bourre J-M, Durand G, Pascal G, Youyou A. Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat. J Nutr. 1989 ; 119: 15-22 (Pubitemid 19059526)
19. Salem N, Moriguchi T, Greiner RS, et al. Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids. J Mol Neurosci. 2001 ; 16: 299-307 (Pubitemid 32664792)
20. Bourre JM, Francois M, Youyou A, et al. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr. 1989 ; 119: 1880-1892 (Pubitemid 20063881)
21. Bourre JM, Dumont O, Pascal G, Durand G. Dietary alpha-linolenic acid at 1.3 g/kg maintains maximal docosahexaenoic acid concentration in brain, heart and liver of adult rats. J Nutr. 1993 ; 123: 1313-1319 (Pubitemid 23207056)
22. Simopoulos AP, Leaf A, Salem N. Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2000 ; 63 (3). 119-121
23. Crawford MA, Sinclair AJ Lipids, Malnutrition and the Developing Brain. Elliott K Knight J, ed. Amsterdam: Associated Scientific Publishers ; 1972: 267-287.
24. Sinclair AJ. Long chain polyunsaturated fatty acids in the mammalian brain. Proc Nutr Soc. 1975 ; 34: 287-291
25. Broadhurst CL, Cunnane SC, Crawford MA. Rift Valley lake fish and shellfish provided brain-specific nutrition for early Homo. Br J Nutr. 1998 ; 79 (1). 3-21 (Pubitemid 28058590)
26. Eaton SB, Eaton SB, Sinclair AJ, Cordain L, Mann NJ. Dietary intake of long-chain polyunsaturated fatty acids during the Paleolithic. World Rev Nutr Diet. 1998 ; 83: 12-23 (Pubitemid 128081428)
27. Simopoulos AP. Overview of evolutionary aspects of ω-3 fatty acids in the diet. World Rev Nutr Diet. 1998 ; 83: 1-11 (Pubitemid 128081427)
28. Uauy R, Mena P, Rojas C. Essential fatty acids in early life: structural and functional role. Proc Nutr Soc. 2000 ; 59: 3-15 (Pubitemid 30316601)
29. Salem N New Roles for Selective Nutrients. Spiller GA Scala J, ed. New York: Alan R. Liss ; 1989: 109-228.
30. Mitchell DC, Straume M, Litman BJ. Role of sn-2-polyunsaturated lipids and control of membrane receptor conformational equilibrium: effects of cholesterol and acyl chain unsaturation on the metarhodopsin I-metarhodopsin II equilibrium. J Biochem. 1992 ; 31: 662-670
31. Mitchell DC, Litman B. Effect of cholesterol on membrane order and dynamics in highly polyunsaturated phospholipid bilayers. Biophys J. 1998 ; 75: 896-908 (Pubitemid 28357530)
32. Huster D, Arnold K, Garwrish K. Influence of docosahexaenoic acid and cholesterol on lateral domain organization in phospholipid mixtures. J Biochem. 1998 ; 37 (49). 17299-17308 (Pubitemid 29013788)
33. Litman BJ, Mitchell DC. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids. 1996 ; 31: S193 - S197
34. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995 ; 62: 1-9
35. Stoll AL, Locke CA, Marangell LB, Severus WE. Omega-3 fatty acids and bipolar disorder: a review. Prostaglandins Leukot Essent Fatty Acids. 1999 ; 60: 329-337 (Pubitemid 29401788)
36. Martin RE. Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells. J Neurosci Res. 1998 ; 56 (6). 805-813 (Pubitemid 28544381)
37. Wainwright PE, Bulman-Fleming MB, Levesque S, Mutsaers L, McCutcheon D. A saturated-fat diet during development alters dendritic growth in mouse brain. Nutr Neurosci. 1998 ; 1: 49-58
38. Ikemoto A, Nitta A, Furukawa S, Ohishi M, Nakamura A, Fujii Y. Dietary n-3 deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett. 2000 ; 285: 99-102 (Pubitemid 30227629)
39. Walter RC, Buffler RT, Bruggemann JH, Guillaume MM, Berhe SM, Negassi B. Early human occupation of the Red Sea coast of Eritrea during the last interglacial. Nature. 2000 ; 405 (6782). 65-69 (Pubitemid 30321815)
40. Sinclair AJ, O'Dea K, Dunstan G, Ireland PD, Niall M. Effects on plasma lipids and fatty acid composition of very low fat diets enriched with fish or kangaroo meat. Lipids. 1987 ; 22 (7). 523-529
41. Naughton JM, O'Dea K, Sinclair AJ. Animal foods in traditional Australian Aboriginal diets: polyunsaturated and low in fat. Lipids. 1986 ; 21 (11). 684-690
42. McIntyre RS, O'Donovan C. The human cost of not achieving full remission in depression. Can J Psychiatry. 2004 ; 49: 10S - 16S (Pubitemid 38506487)
43. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry. 1999 ; 56: 829-835 (Pubitemid 29420704)
44. Ross BM, Ward P, Glen I. Delayed vasodilatory response to methylnicotinate in patients with unipolar depressive disorder. J Affect Disord. 2004 ; 82: 285-290 (Pubitemid 39370831)
45. Ross BM, Sieswerda LE ω-3 Fatty Acid Research. Teale MC, ed. New York: Nova Science Publishers ; 2006: 276-312.
46. Sontrop J, Campbell MK. ω-3 Polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med. 2006 ; 42: 4-13 (Pubitemid 43148942)
47. Ross BM. ω-3 Fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism. Med Hypotheses. 2007 ; 68: 515-524 (Pubitemid 46043407)
48. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid composition in major depression: decreased ω-3 fractions in cholesteryl esters and increased C20:4 ω-6/C20:5 ω-3 ratio in cholesteryl esters and phospholipids. J Affect Disord. 1996 ; 38: 35-46
49. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered ω-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999 ; 85: 275-291 (Pubitemid 29202389)
50. Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr. 2003 ; 78: 40-46 (Pubitemid 39655246)
51. Frasure-Smith N, Lesperance F, Julien P. Major depression is associated with lower ω-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry. 2004 ; 55: 891-896 (Pubitemid 38526301)
52. Peet M, Murphy B, Shay J, Horrobin D. Depletion of ω-3 PUFA levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998 ; 43: 315-319 (Pubitemid 28137622)
53. Edwards R, Peet M, Shay J, Horrobin D. ω-3 Polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998 ; 48: 149-155 (Pubitemid 28244216)
54. de Vriese SR, Christophe AB, Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci. 2003 ; 7 (73). 3181-3187 (Pubitemid 37242978)
55. Jans LAW, Giltay EJ, Van der Does AJW. The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression. Br J Nutr. 2010 ; 104: 1577-1585
56. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ. ω-3 Polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry. 2006 ; 163: 1100-1102 (Pubitemid 44464499)
57. Logan A. Omega-3 fatty acids and major depression: a primer for the mental health professional. Lipids Health Dis. 2004 ; 3: 25
58. Moriguchi T, Geiner RS, Salem N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem. 2000 ; 75: 2563-2573
59. Morris MC, Evans DA, Tangney C, Bienias J, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol. 2005 ; 62: 1849-1853 (Pubitemid 41785078)
60. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv. 2001 ; 52: 529-531 (Pubitemid 32275317)
61. Hibbeln JR. Fish oil consumption and major depression. Lancet. 1998 ; 351: 1213 (Pubitemid 28171846)
62. Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P. Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord. 2004 ; 82: 447-452 (Pubitemid 39536178)
63. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord. 2002 ; 69: 15-29 (Pubitemid 34722867)
64. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J. Is low dietary intake of ω-3 fatty acids associated with depression?. Am J Psychiatry. 2004 ; 161: 567-569 (Pubitemid 38326115)
65. Otten W, Iaizzo PA, Eichinger HM. Effects of a high n-3 fatty acid diet on membrane lipid composition of heart and skeletal muscle in normal swine and in swine with the genetic mutation for malignant hyperthermia. J Lipid Res. 1997 ; 38: 2023-2034 (Pubitemid 27468011)
66. Keelan M, Hui DY, Wild G, Clandinin MT, Thomson AB. Variability of the intestinal uptake of lipids is genetically determined in mice. Lipids. 2000 ; 35 (8). 833-837
67. Day R, Nielsen JA, Korten A, et al. Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization. Cult Med Psychiatry. 1987 ; 11 (2). 123-205
68. Sim K, Chua TH, Chan YH, Mahendran R, Chong SA. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study. J Psychiatr Res. 2006 ; 40 (7). 656-663 (Pubitemid 44349097)
69. Goldner EM, Hsu L, Waraich P, Somers JM. Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry. 2002 ; 47 (9). 833-843 (Pubitemid 35440149)
70. Sims A Symptoms in the Mind: An Introduction to Descriptive Psychopathology. 3 rd ed. Philadelphia: W. B. Saunders ; 2003 :
71. Marčinko D, Marčinko V, KarloviA D, et al. Serum lipid levels and suicidality among male patients with schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007 ; 32 (1). 193-196
72. Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry. 2000 ; 47 (1). 8-21 (Pubitemid 30016075)
73. Keshavan MS, Stanley JA, Pettegrew JW. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part II. Biol Psychiatry. 2000 ; 48: 369-380
74. Ross BM, Turenne S, Mosczynska A. Differential alteration of phospholipase A2 activities in brains of patients with schizophrenia. Brain Res. 1999 ; 821: 407-413 (Pubitemid 29222805)
75. Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs. 2005 ; 65 (8). 1051-1059 (Pubitemid 40840003)
76. Christensen O, Christensen E. Fat consumption and schizophrenia. Acta Psychiatr Scan. 1988 ; 78 (5). 587-591
77. Mellor JE, Laugharne JD, Peet M. Omega-3 fatty acid supplementation in schizophrenic patients. Hum Psychopharmacol Clin Exp. 1996 ; 11 (1). 39-46 (Pubitemid 26068357)
78. Sumiyoshi T, Matsui M, Itoh H, et al. Essential polyunsaturated fatty acids and social cognition in schizophrenia. Psychiatry Res. 2008 ; 157: 87-93 (Pubitemid 350166534)
79. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry. 2001 ; 49: 510-522 (Pubitemid 32226409)
80. Connor WE, Neuringer M, Lin DS. Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J Lipid Res. 1990 ; 31: 237-247 (Pubitemid 20089038)
81. Peet M, Laugharne JD, Horrobin DF, Rangarajan N. Depleted red cell membrane essential fatty acids in drug treated schizophrenic patients. J Psychiatr Res. 1995 ; 29: 227-232
82. Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res. 2002 ; 58: 1-10 (Pubitemid 35287278)
83. Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res. 2003 ; 62: 195-204 (Pubitemid 36773928)
84. Peet M, Shah S, Selvam K, Ramchand CN. Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients. World J Biol Psychiatry. 2004 ; 5 (2). 92-99
85. Reddy RD, Keshavan MS, Yao JK. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull. 2004 ; 30: 901-911 (Pubitemid 40469524)
86. Ranjekar PK, Hinge A, Hegde MV, et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatr Res. 2003 ; 121 (2). 109-122 (Pubitemid 37500981)
87. Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty Acids. 2003 ; 69 (6). 393-399 (Pubitemid 37464048)
88. Doris AB, Wahle K, MacDonald A, et al. Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia. Schizophr Res. 1998 ; 31: 185-196 (Pubitemid 28307959)
89. Maclean R, Ward PE, Glen I, Roberts SJ, Ross BM. On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis. Progr Neuropsychopharmacol Biol Psychiatry. 2003 ; 27 (6). 927-933 (Pubitemid 37141381)
90. Goodwin FK, Jamison KR Manic Depressive Illness. Oxford, England: Oxford University Press ; 1990 :
91. Montgomery P, Richardson AJ. Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev. 2008 ; ( 2 ):
92. Basco Ramirez M The Bipolar Workbook: Tools for Controlling Your Mood Swings. New York: Guilford ; 2006 :
93. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995 ; 152: 1635-1640
94. Schwarz E, Prabakaran S, Whitfield P, et al. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res. 2008 ; 7 (10). 4266-4277
95. Horrobin DF, Bennett CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis possible candidate genes. Prostaglandins Leukot Essent Fatty Acids. 1999 ; 60 (4). 217-234 (Pubitemid 29306598)
96. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999 ; 56 (5). 407-412 (Pubitemid 29215428)
97. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest. 1993 ; 91: 651-660 (Pubitemid 23064151)
98. Tappia PS, Ladha S, Clark DC, Grimble RF. The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cytokine production in rats fed a variety of fat diets. Mol Cell Biochem. 1997 ; 166: 135-143 (Pubitemid 27085095)
99. Chiu CC, Huang SY, Su KP, et al. Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol. 2003 ; 13 (2). 99-103
100. Igarashi M, Ma K, Gao F, et al. Brain lipid concentrations in bipolar disorder. J Psych Res. 2010 ; 44: 177-182
101. Osher Y, Bersudsky Y, Belmaker RH. Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry. 2005 ; 66: 726-729 (Pubitemid 40942418)
102. Turnbull T, Cullen-Drill M, Smaldone A. Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review. Arch Psychiatr Nurs. 2008 ; 22: 305-311
103. Marangell LB, Suppes T, Ketter TA, et al. Omega-3 fatty acids in bipolar disorder: clinical and research considerations. Prostaglandins Leukot Essent Fatty Acids. 2006 ; 75 (4-5). 315-321 (Pubitemid 44442915)
104. Sublette ME, Bosetti F, DeMar JC, et al. Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord. 2007 ; 9 (7). 759-765 (Pubitemid 350042412)
105. Lieb J, Karmali R, Horrobin D. Elevated levels of prostaglandin E2 and thromboxane B2 in depression. Prostaglandins Leukot Med. 1983 ; 10: 361-367 (Pubitemid 13162267)
106. Diagnostic and statistical manual of mental disorders. 4 th ed Washington, DC: American Psychiatric Association ; 2000 :
107. Bauer ME, Wieck A, Lopes RP, Teixeira AL, Grassi-Oliveira R. Interplay between neuroimmunoendocrine systems during post-traumatic stress disorder: a minireview. Neuroimmunomodulation. 2010 ; 17 (3). 192-195
108. ZoričiA Z, KarloviA D, Buljan D, MarušiA S. Comorbid alcohol addiction increases aggression level in soldiers with combat-related posttraumatic stress disorder. Nord J Psychiatry. 2003 ; 57: 199-202
109. KozariA-KovačiA D, Hercigonja DK, GrubišiA-Ili A M. Posttraumatic stress disorder and depression in soldiers with combat experiences. Croat Med J. 2001 ; 42: 165-170
110. KarloviA D, Buljan D, Martinac M, Marčinko D. Serum lipid concentrations in Croatian veterans with post-traumatic stress disorder, post-traumatic stress disorder comorbid with major depressive disorder, or major depressive disorder. J Korean Med Sci. 2004 ; 19: 431-436 (Pubitemid 38859836)
111. Solomon SD, Gerrity ET, Muff AM. Efficacy of treatments for posttraumatic stress disorder: an empirical review. JAMA. 1992 ; 268: 633-638
112. Davidson JR, Colket JT. The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. Int Clin Psychopharmacol. 1997 ; 12: 41-45 (Pubitemid 27171195)
113. DÅubur KulenoviA A, KučukaliA A, Maleč D. Changes in plasma lipid concentrations and risk of coronary artery disease in army veterans suffering from chronic posttraumatic stress disorder. Croat Med J. 2008 ; 49 (4). 506-514
114. KarloviA D, Martinac M, Buljan D, ZoričiA Z. Relationship between serum lipid concentrations and posttraumatic stress disorder symptoms in soldiers with combat experiences. Acta Medica Okayama. 2004 ; 58 (1). 23-27 (Pubitemid 38406280)
115. Solter V, Thaller V, KarloviA D, CrnkoviA D. Elevated serum lipids in veterans with combat-related chronic posttraumatic stress disorder. Croat Med J. 2002 ; 43 (6). 685-689 (Pubitemid 41490283)
116. Kagan BL, Leskin G, Haas B, Wilkins J, Foy D. Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999 ; 45: 374-377 (Pubitemid 29100047)
117. Kaplan Z, Matar M, Kamin R, Cohen H. Possible deleterious effects of adjunctive omega-3 fatty acids in post-traumatic stress disorder patients. Neuropsychiatr Dis Treat. 2005 ; 1 (2). 187-190